Impact of Lymphocytes in Soft Tissue Sarcomas
Author Information
Author(s): Sorbye Sveinung W., Kilvaer Thomas, Valkov Andrej, Donnem Tom, Smeland Eivind, Al-Shibli Khalid, Bremnes Roy M., Busund Lill-Tove
Primary Institution: University Hospital of North Norway
Hypothesis
The study aimed to clarify the prognostic significance of lymphocyte infiltration in soft tissue sarcomas (STS).
Conclusion
High density of CD20+ lymphocytes in STS with wide resection margins is an independent positive prognostic indicator for these patients.
Supporting Evidence
- Increased numbers of CD4+ and CD20+ lymphocytes correlated with improved disease-specific survival in patients with wide resection margins.
- A high number of CD20+ lymphocytes was an independent positive prognostic factor for disease-specific survival.
- Patients with non-wide resection margins showed that increased CD3+ lymphocytes correlated with shorter disease-specific survival.
Takeaway
This study found that having more CD20+ immune cells in certain tumors can help patients live longer after surgery.
Methodology
The study used tissue microarrays and immunohistochemistry to evaluate lymphocyte types in tumor samples from 249 patients.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the selection of patient records.
Limitations
The study was retrospective and relied on historical patient data, which may limit the applicability of the findings.
Participant Demographics
Patients included 44% males, with ages ranging from 0 to 91 years, and included both Norwegian and Russian patients.
Statistical Information
P-Value
P = 0.006 for CD20+ lymphocytes in wide resection margins.
Confidence Interval
CI 95% = 1.6–18.6
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website